Effects of Risk Presentation Format and Frequently Asked Questions on Breast Cancer Risk Skepticism
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- University of Colorado, Denver
- Study ID
- NCT07793721
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 39 Years - 74 Years
- Healthy Volunteers
- Accepted
Interventions
- Risk Presentation Format — BEHAVIORALParticipants receive a personalized breast cancer risk estimate generated by the Gail Model. The format of the estimate varies by random assignment across two dimensions: temporal framing (5-year, 10-year, or lifetime risk) and denominator (risk expressed out of 100 women or out of 1,000 women). All other elements of the risk presentation are held constant across conditions.
- Frequently Asked Questions Exposure — BEHAVIORALParticipants receive a personalized breast cancer risk estimate generated by the Gail Model and then view an interactive FAQ document. The FAQ document was developed from qualitative interviews with women who had previously rejected their risk estimates and addresses common questions about how breast cancer risk is calculated, what factors the model does and does not include, what different risk levels mean, and how to discuss results with a physician. FAQ items are displayed as expandable questions; participants click to reveal answers. All participants receive the same FAQ document.
Study Details
The purpose of this study is to find out whether the way a breast cancer risk estimate is presented affects how women feel about their risk and whether they believe the estimate is accurate for them. Women aged 39-74 will complete an online survey in which they receive a personalized breast cancer risk estimate using the Breast Cancer Risk Assessment Tool (BCRAT). The study includes two experiments. In the first experiment, women are randomly assigned to receive their estimate in different formats: some will see their risk over 5 years, 10 years, or a lifetime, and some will see their risk expressed out of 100 women or out of 1,000 women. In the second experiment, women receive their estimate and then have the opportunity to read answers to frequently asked questions about how breast cancer risk is calculated and what the estimate means. In both experiments, women are asked whether they believe the estimate reflects their true risk. Both experiments are conducted online through a national survey panel.
Key Dates
- First listed
- Aug 28, 2026
- Start date
- Sep 1, 2026
- Status verified
- Aug 2026
- Primary completion
- Feb 1, 2027
- Completion
- Apr 1, 2027
Study Design
- Enrollment
- 3,000 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- FACTORIAL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: 5 Year Risk AND N-in-100 Presentation
- Experimental: 10 Year Risk AND N-in-100 Presentation
- Experimental: Lifetime Risk AND N-in-100 Presentation
- Experimental: 5 Year Risk AND N-in-1000 Presentation
- Experimental: 10 Year Risk AND N-in-1000 Presentation
- Experimental: Lifetime Risk AND N-in-1000 Presentation
Primary Outcome Measure
Risk Skepticism [ Time Frame: Day 1 ]
Central Contacts
- Emily A Vidal, MS303-724-5426
- Laura D Scherer, PhD303-724-3278
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Colorado Anschutz Medical Campus | Aurora | Colorado | 80045 | Laura D Scherer, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Aurora, CO
Related Studies
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After LumpectomyPHASE3 · Recruiting · Rocky Mountain Cancer Centers · Aurora, Colorado
- The Immune System's Response to Young Women's Breast CancerRecruiting · University of Colorado, Denver · Aurora, Colorado
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado